ACE PHARMA
ActiveSummary
ACE PHARMA has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €221,792 and a net result of €1,837. Equity remains stable across the filed financial years (±2.2% per year). Its solvency ranks better than 85% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Owners and capital
Owners
2 ownersChain of control
- CELOR MANAGEMENT
- ACE PHARMA
Highest known parent: CELOR MANAGEMENT. The sources do not say who stands above it.
Owners 2
- CELOR MANAGEMENTparent60%
-
40%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.